All together, these results indicate that JNK signalling plays a central role in AD neurodegeneration, but JNK also has emerged as a potential biomarker for early diagnosis, and a potential target to prevent neuronal cell death [55]. The gene discussed is MAPK8; the disease is Alzheimer disease.